Related Experiment Video
Updated: Feb 28, 2026

04:36
Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors
Published on: October 17, 2025
1.0K
Intracranial and Systemic Response to Alectinib in a Patient with RET-KIF5B Oncogenic Fusion
Vamsidhar Velcheti1, Manmeet Ahluwalia1
1Department of Solid Tumor Oncology, Cleveland Clinic, Cleveland, Ohio.
Abstract
No abstract available in PubMed .
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Intracellular Signaling Affects Focal Adhesions
3.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
3.7K

